Skip to main content
TERUMO CORPORATION logo

TERUMO CORPORATION — Investor Relations & Filings

Ticker · 4543 ISIN · JP3546800008 LEI · 353800JX1R4582QVK932 SGX Manufacturing
Open in API
Filings indexed 89 across all filing types
Latest filing 2021-06-23 Governance Information
Country JP Japan
Listing SGX 4543

About TERUMO CORPORATION

https://www.terumo.co.jp/

Terumo Corporation is a global medical technology company that develops, manufactures, and markets a broad portfolio of medical devices, equipment, and solutions. Its core business activities are centered on several key areas: Cardiac and Vascular, Blood and Cell Technologies, and Hospital and Pharmaceutical Solutions. The Cardiac and Vascular business provides products for interventional procedures, neurovascular therapies, and cardiovascular surgery. The Blood and Cell Technologies division offers solutions for blood transfusion, apheresis, and cell therapy processing. The company also supplies general hospital products, including infusion systems and medical disposables, alongside life care products for consumers and specialized pharmaceutical solutions that integrate drugs with delivery devices.

Recent filings

Filing Released Lang Actions
内部統制報告書－第106期(令和2年4月1日－令和3年3月31日)
Governance Information Classification · 100% confidence The document is an 'Internal Control Report' (内部統制報告書) filed by Terumo Corporation in accordance with the Financial Instruments and Exchange Act of Japan. It details the company's framework, scope, and evaluation results regarding internal controls over financial reporting. Since this is a specific regulatory filing required by Japanese law regarding internal controls and does not fit into categories like 10-K (Annual Report) or ER (Earnings Release), it is best classified as a Regulatory Filing (RNS).
2021-06-23 Japanese
確認書
Regulatory Filings Classification · 95% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act, Article 24-4-2, Paragraph 1. It serves as an officer certification confirming the accuracy of the company's Annual Securities Report (有価証券報告書). According to the 'Certification Rule', documents that are primarily officer certifications or attestations, even if they reference a specific report, should be classified as Regulatory Filings (RNS) rather than the report itself. FY 2021
2021-06-23 Japanese
有価証券報告書－第106期(令和2年4月1日－令和3年3月31日)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains the standard cover page with the filing date (2021-06-23), the fiscal year (106th period, 2020-04-01 to 2021-03-31), and extensive XBRL tagging data typical of a comprehensive annual financial filing. FY 2021
2021-06-23 Japanese
四半期報告書－第106期第3四半期(令和2年10月1日－令和2年12月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Terumo Corporation, covering the third quarter of the 106th fiscal period (October 1, 2020, to December 31, 2020). It contains detailed financial statements, management analysis (MDA), and corporate information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2021
2021-02-08 Japanese
訂正有価証券報告書－第105期(平成31年4月1日－令和2年3月31日)
Regulatory Filings
2020-12-21 Japanese
訂正有価証券報告書－第104期(平成30年4月1日－平成31年3月31日)
Regulatory Filings
2020-12-21 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.